glp-1 news today november 5 2025 Orforglipron, an Oral Small-Molecule Receptor Agonist for Obesity 5, DOI: 10.1056/NEJMdo008238 New for the treatment of obesity - and so many additional indications being studied GLP-1 Pipeline Update: November 2025

with other medicines for the maintenance treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adults and children 12 years of age and older whose disease is not controlled

Liraglutides safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial

With millions of Americans already taking GLP-1 medications and use continuing to grow, these effects on preventing and treating substance use disorders could have significant impact at the population level

Levothyroxine is a thyroid hormone

Certain types of sushi with a lower carb count, such as maki (as opposed to uramaki) can help you stay in range

Not unlike domestic victims, respondents indicated that most international victims were not aware that they were victims of a crime